<DOC>
	<DOC>NCT00000227</DOC>
	<brief_summary>The purpose of this study is to evaluate open buprenorphine dosing with dose choice.</brief_summary>
	<brief_title>Alternate-Day Buprenorphine Administration. Phase VIII - 9</brief_title>
	<detailed_description />
	<mesh_term>Opioid-Related Disorders</mesh_term>
	<mesh_term>Buprenorphine</mesh_term>
	<criteria>Please contact site for information.</criteria>
	<gender>All</gender>
	<minimum_age>25 Years</minimum_age>
	<maximum_age>48 Years</maximum_age>
	<verification_date>July 1996</verification_date>
</DOC>